- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05357131
Neurophysiological Correlates of Dissociation Induced by Virtual Reality Hypnosis.
Neurophysiological Correlates of Dissociation Induced by Virtual Reality Hypnosis (VRH) and Hypnosis (HYP) in a Healthy Participants.
Hypnosis and virtual reality are potential tools in treating acute pain. Nevertheless, the neurophysiological correlates of such tools used together, i.e. 'virtual reality hypnosis' (VRH) (Patterson et al., 2004) remain mostly understudied. This study aims to improve our knowledge and understanding of the dissociation (i.e., a mental separation of components of behaviours that normally would be processed together) occurring during VRH. This is a randomized controlled study that will be conducted on healthy participants. As the final goal is to propose such a tool in the clinical context, a clinical application will also be carried out subsequently.
Thus the principal outcome is to study dissociation in the context of VRH from a behavioral and neurophysiological point of view.
Secondary objectives aim at identifying factors that influence the dissociative effect seen in VRH, as well as measuring traits of hypnotisability, absorption, immersive abilities, dissociation trait and state, pain, and anxiety levels that might impact the effectiveness of such a tool.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The protocol will follow the following steps:
Before the experiment:
- A medical screening of the medical history and of any concomitant medications will be performed to eligibility.
- The 6-item Elkins Hypnotisability Scale (EHS) will be used to assess participant hypnotisability.
- Questionnaire sur la Propension à l'Immersion (QPI) will be used to assess participant immersion tendency.
Experimental session: Cross-over and within-participant control design i. Visual Analogue Scale (VAS) :
- Anxiety.
- Pain. ii. EEG Resting-state (5-Min.). iii. EEG VRH or EEG Hypnosis alone (HYP) (15-Min.). iv. Adverse Events (AE) during the protocol will be recorded. v. Narrative recording. vi. VAS :
- Dissociation
- Absorption
- Pain
- Anxiety
- Arousal/wakefulness
- Automaticity vii. Time perception (open question) viii. CyberSickness (CSQ) (only if VRH) ix. Presence Questionnaire x. Satisfaction questionnaire xi. Washout Phase (30-Min.) during which we will administer :
- Six-item State-Trait Anxiety Inventory (STAI-6) .
- Tellegen Absorption Scale .
- Dissociative Experience Scales (DES) . xii. VAS:
- Anxiety
- Pain xiv. Adverse Events during the protocol will be recorded. xv. Narrative recording. xvi. EEG HYP or EEG VRH Phase (15-Min.). xvii. VAS:
- Dissociation
- Absorption
- Pain
- Anxiety
- Arousal/wakefulness
- Time perception xviii. CSQ (only if VRH) xix. Presence Questionnaire. xx. Satisfaction Questionnaire .
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Liège, Belgium, 4000
- Chu of Liège
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria: Subject more than 18 years old and equal or less than 65 years old.
Exclusion Criteria:
- Low auditory and/or visual acuity precludes the use of the device.
- Head or face wounds precluding the use of the device.
- Schizophrenia, dissociative disorder or any other psychiatric disorder.
- Non-proficiency in French (Research language).
- Patient under 18 years old.
- Phobia of deep water.
- Allergy to cutaneous electrodes.
- Chronic pain and/or chronic analgesics consumption.
- Medication affecting the autonomic nervous system.
- Dizziness.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Healthy Volunteers - Hypnosis without VR (HYP )
Cross-over and within-participant control design: Participants will receive recorded hypnosis without VR.
|
HYP will last for 15 minutes including an induction phase of 5 minutes.
The hypnotic audio script "Heaven of Peace" developped/recorded by Pr.
M-E.
Faymonville will be used.
|
|
Experimental: Healthy Volunteers - Hypnosis with VR (VRH)
Cross-over and within-participant control design: Participants will receive hypnosis with VR.
|
The VRH intervention will use the Aqua video session developed by Oncomfort.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dissociation state
Time Frame: During the procedure
|
Corresponds to a dissociation between the bodily sensations and the actual environment that one feels in a particular situation.
will be assessed with a numerical rating scale (0= no dissociation; 10 = dissociation from environment).
|
During the procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain intensity
Time Frame: During the procedure
|
The amount of pain one experiences in a particular situation.
Will be assessed with a visual analogy scale, 0= no pain at all; 10= worst pain imaginable.
|
During the procedure
|
|
Dissociation trait
Time Frame: During the procedure
|
The amount of dissociation one experiences in one's daily life.
Will be assessed with the Dissociative Experience Scale, the higher the score, the more one experiences dissociation in one's daily life.
|
During the procedure
|
|
Absorption trait
Time Frame: During the procedure
|
The tendency to become fully involved in a perceptual, imaginative or ideational experience.
Will be assessed with the Tellegen Absorption Scale, the higher the score the higher the absorption in the daily life.
|
During the procedure
|
|
Immersion propensity (trait)
Time Frame: During the procedure
|
Immersion propensity is the amount of sensory input the virtual reality system creates.
Will be assessed with the Immersion Propensity questionnaire.
The higher the score, the more one is immersed in the virtual environments.
|
During the procedure
|
|
Anxiety state
Time Frame: During the procedure
|
The amount of anxiety one experiences in a particular situation.
Will be assessed with a visual analogy scale.
a score = 0 means no anxiety at all, while a score = 10 means most anxiety ever felt.
|
During the procedure
|
|
Automaticity
Time Frame: During the procedure
|
A non-voluntary response related to the content of a communication that is intended to be a suggestion.
Will be assessed with a numerical rating scale : 0= perfect control; 10 = passive witness.
|
During the procedure
|
|
Time perception
Time Frame: During the procedure
|
Open-ended question about one's impression of the duration of the VHR and HYP sessions.
|
During the procedure
|
|
Cybersickness
Time Frame: During the procedure
|
Assesses the sickness one might experience after the VRH.
Will be assessed with the Cybersickness questionnaire.
The higher the score, the more one has experience sickness during the VRH.
|
During the procedure
|
|
Presence
Time Frame: During the procedure
|
Refers to the degree to which the subject experiences being in the virtual environment.
Will be assessed with the presence questionnaire, the higher the score the higher one has the feeling of really being in the virtual environment.
|
During the procedure
|
|
Satisfaction of the participant
Time Frame: During the procedure
|
Assesses the overall satisfaction one has had with the VRH and HYP session.
Will be assessed by a self-made satisfaction questionnaire, the higher the score, the more one is satisfied with the experience.
|
During the procedure
|
|
Hypnotisability
Time Frame: During the procedure
|
The susceptibility one has concerning hypnosis. Will be assessed with the Elkins Hypnotizability Scale. A score : 0-3 : low hypnotizability 4-7: medium hypnotizability 8-11 : high hypnotizability 12 : very high hypnotizability |
During the procedure
|
|
Anxiety trait
Time Frame: During the procedure
|
Level of anxiety one experiences in one's daily life.
Will be assessed with the STAI-6 questionnaire.
The higher the score, the higher the anxiety one feels in one's daily life.
|
During the procedure
|
|
Absorption state
Time Frame: During the procedure
|
The amount of absroption one experiences in a particular situation.
Will be assessed with a numercial rating scale, 0 = no absorption; 10 = fully absorption by the experience.
|
During the procedure
|
|
Arousal/wakefulness
Time Frame: During the procedure
|
The amount of arousal one experiences in a particular situation.
Will be assessed with a visual analogy scale, 0=not aroused, awaked; 10 = completely aroused, awake.
|
During the procedure
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Audrey VANHAUDENHUYSE, PhD, Chu of Liège
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- QuDDoS - Phase-I
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Danone NutriciaCompletedHealthy Elderly | Healthy VolunteersChina
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
Clinical Trials on Hypnosis without VR (HYP)
-
University Hospital TuebingenMilton Erickson Gesellschaft für klinische Hypnose; Milton Erickson Gesellschaft...Active, not recruiting
-
University of WashingtonNational Multiple Sclerosis SocietyCompleted
-
University of WashingtonNational Multiple Sclerosis Society; The University of QueenslandCompletedMultiple Sclerosis | FatigueUnited States
-
The Hong Kong Polytechnic UniversityNot yet recruitingNeoplasms | Pain | Nausea | Vomiting | Child | Sleep Hygiene
-
The Hong Kong Polytechnic UniversityHong Kong Children's Hospital; Research Grants Council, Hong KongNot yet recruiting
-
National Institute of General Medical Sciences...National Institutes of Health (NIH)Completed
-
Bnai Zion Medical CenterRecruiting
-
Assistance Publique - Hôpitaux de ParisCompletedUsing Virtual Reality to Prevent Pre-operative Anxiety in Ambulatory Surgery Patients (PACAH-UCA HV)Surgery | Hallux ValgusFrance
-
University of LiegeUnknownPain, Postoperative | Fatigue | Anxiety | Thoracic SurgeryBelgium
-
University of LiegeOncomfort; BiowinNot yet recruiting